Open main menu

Biolecture.org β

Essay1

Revision as of 11:43, 10 June 2016 by imported>S

In the last date of June, survice for genomic analysis is out of control from government. So, companies are concentrating to the service range which allows by the rule. Many experts says this is well-customized genomic analysis and it will be basis of realization of accurate medical treatment. However, critics say it is needed to readjust for prevention of disease and fostering industry. In fact, genomic analysis is purpose on treatment of disease, but if the analysis become a white elephant, people will not use that technology at all. Actually most of disease can reveal in hospital by doctor, so many people are intersted in disease that occur in the 'future'. As shown in the report, the service do not include for the critical disease such as cancer. There could be a person who don't want to give a genomic data just for his(or her) caugh! They want to know their future-possible disease and want to prevent from the disease. Therefore, related companies need to expand the range of genomic analysis for the disease. Then many people will use that technique because people want to live longer than now.